Stocks and Investing
Stocks and Investing
Tue, May 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 29, 2023
[ 12:00 AM ] - WOPRAI
Sun, May 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (UBX) at Strong Buy with Increased Target to $6 on, May 26th, 2023
Yigal Nochomovitz of Citigroup, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Increased Target from $5 to $6 on, May 26th, 2023.
Yigal has made no other calls on UBX in the last 4 months.
There are 4 other peers that have a rating on UBX. Out of the 4 peers that are also analyzing UBX, 0 agree with Yigal's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Yigal
- Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Wednesday, May 10th, 2023
- Andreas Argyrides of "Wedbush" Maintained at Buy with Decreased Target to $3 on, Tuesday, April 25th, 2023
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, March 28th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023
Contributing Sources